Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.7650
+0.0750 (4.44%)
NASDAQ · Last Trade: Feb 18th, 11:41 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors